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AbsTrACT
Objective To investigate whether exposure to 
particulates and combustion products may explain 
the association between certain occupations and 
amyotrophic lateral sclerosis (aLs) risk in a large, 
multicentre, population-based, case–control study, based 
on full job histories, using job-exposure matrices, with 
detailed information on possible confounders.
Methods population-based patients with aLs and 
controls were recruited from five registries in the 
Netherlands, Ireland and Italy. Demographics and data 
regarding educational level, smoking, alcohol habits 
and lifetime occupational history were obtained using 
a validated questionnaire. Using job-exposure matrices, 
we assessed occupational exposure to silica, asbestos, 
organic dust, contact with animals or fresh animal 
products, endotoxins, polycyclic aromatic hydrocarbons 
and diesel motor exhaust. Multivariate logistic regression 
models adjusting for confounding factors were used to 
determine the association between these exposures and 
aLs risk.
results We included 1557 patients and 2922 controls. 
associations were positive for all seven occupational 
exposures (ORs ranging from 1.13 to 1.73 for high 
vs never exposed), and significant on the continuous 
scale for silica, organic dust and diesel motor exhaust 
(p values for trend ≤0.03). additional analyses, adding 
an exposure (one at a time) to the model in the single 
exposure analysis, revealed a stable OR for silica. We 
found similar results when patients with a C9orf72 
mutation were excluded.
Conclusion In a large, multicentre study, using 
harmonised methodology to objectively quantify 
occupational exposure to particulates and combustion 
products, we found an association between aLs risk and 
exposure to silica, independent of the other occupational 
exposures studied.
INTrOduCTION
The aetiology of the fatal neurodegenerative 
disease, amyotrophic lateral sclerosis (ALS), is still 
largely unknown, but best described as the interplay 
of genetic and environmental factors.1 2 Regarding 
environmental factors, occupational history has 
been studied extensively3; an association with ALS 
has been reported for farmers,4 veterinarians,3 5 
firefighters,6 flight attendants7 and truck drivers.8 
Exposure to particulates (silica, asbestos, animal 
contact, endotoxin exposure) and combustion 
products (polycyclic aromatic hydrocarbons (PAH), 
diesel motor exhaust (DME)) could hypothetically 
link these occupations with ALS.
However, not all studies have reported posi-
tive associations for either the occupation or the 
proposed underlying exposure.9–13 This may, in 
part, be due to methodological differences between 
these studies, such as study design or data collec-
tion; use of a single occupation to estimate expo-
sure (eg, the longest or last held job) instead of full 
occupational histories; exploration of a single expo-
sure instead of combined exposures; self-reported 
occupational exposures; or inferences about the 
underlying exposures when testing for association 
with occupational groups. In contrast, job-exposure 
matrices (JEM) provide an objective and agent-spe-
cific method for exposure assessment on lifetime 
occupational histories in case–control studies.
We aim to investigate previously suggested asso-
ciations between ALS and occupational exposure to 
particulates and combustion products, based on full 
job histories and using JEMs in a large, multicentre, 
population-based, case–control study with detailed 
information on possible confounders.
MeThOds
study population
All participants were recruited as part of a case–
control study undertaken by the Euro-MOTOR 
consortium between 2011 and 2014. Popula-
tion-based cases representing patients with defi-
nite (laboratory supported), probable or possible 
ALS according to the revised El Escorial criteria14 
were matched to controls based on age, gender and 
residency. The study was carried out in three Euro-
pean countries, over five regions: the Netherlands, 
Ireland, Apulia, Lombardy, and Piedmont and Valle 
d’Aosta in Italy. The overall aim and a more exten-
sive description of this project has been provided 
elsewhere.15 All participants gave written informed 
consent.
data collection
Using the same structured questionnaire, all five 
centres collected demographic characteristics of 
participants and data on their educational level, 
smoking and alcohol drinking habits and lifetime 
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Table 1 Baseline characteristics
Ireland The Netherlands Apulia Lombardy
Piedmont and Valle 
d’Aosta
Patient Control Patient Control Patient Control Patient Control Patient Control
n 177 349 791 1880 141 213 186 190 262 290
Male gender (%) 59.9 60.5 60.4 59.9 57.4 53.1 53.8 53.2 52.7 52.8
Bulbar site of onset (%) 23.7 35.3 26.5 29.6 37.0
Age at survey, mean (SD), 
years
65.1 (11.5) 65.4 (11.0) 64.2 (10.3) 64.0 (9.6) 63.9 (10.8) 63.8 (11.7) 65.3 (10.6) 65.5 (11.1) 65.8 (10.8) 64.2 (11.7)
Education (%)
  ISCED 5-8 16.4 21.8 26.0 28.3 7.6 9.9 9.3 36.4 6.3 15.9
  ISCED 0-4 83.6 78.2 74.0 71.7 92.4 90.1 90.7 63.6 93.7 84.1
C9orf72 repeat expansion* 
(%)
9.2 9.7 NA 8.8 8.8
Smoking (%)
  Current 19.4 11.2 21.5 13.8 22.1 21.0 19.8 18.0 18.9 15.6
  Former 36.6 40.2 45.9 52.6 33.6 26.7 36.3 34.4 28.7 34.6
  Never 44.0 48.6 32.6 33.6 44.3 52.4 44.0 47.6 52.4 49.8
Alcohol (%)
  Current 72.7 75.4 78.1 87.7 54.3 40.5 59.6 62.7 56.4 61.3
  Former 10.5 5.9 8.0 4.0 7.9 2.4 7.6 3.0 6.8 6.3
  Never 16.9 18.6 13.9 8.3 37.8 57.1 32.7 34.3 36.8 32.4
*Missing in C9orf72: 4 (2.3%) in Ireland, 57 (7.2%) in the Netherlands, 139 (98.6%) in Apulia, 106 (57.0%) in Lombardy, 0 (0%) in Piedmont and Valle d’Aosta.
NA, not applicable.
occupational history. In order to allow comparability between 
cohorts, the highest educational degree obtained was categorised 
into International Standard Classification of Education (ISCED) 
0–4 and ISCED 5–8, according to the ISCED 2011.16 Data on 
age were collected at the start and cessation of smoking and 
alcohol drinking. Smoking and alcohol status was categorised 
as never, former or current. Detailed data were gathered on the 
lifetime job history of participants: they were asked to recall all 
their jobs and to describe all job-related activities performed, 
including the start and stop years and hours per week. Job titles 
were coded into the International Standard Classification of 
Occupations (ISCO), version 1968.17
In Ireland and Italy, using the questionnaire as a guide, face-to-
face interviews were held to gather the data. In the Netherlands, 
participants filled in the questionnaire themselves. Participants 
were contacted by telephone to complete or correct the data 
where necessary. Clinical data were collected from patients’ 
medical records.
Classification of occupational exposures
Occupational exposures were estimated to: silica (respirable 
crystalline silica) and asbestos; organic dusts in general and 
specifically animal contact (contact with animals or fresh animal 
products) and endotoxin; and PAH and DME. Estimations 
were performed using the general population DOM-JEM.18–20 
The DOM-JEM is based on the five-digit ISCO 1968 coding,17 
providing an exposure estimate (none, low, high) to each indi-
vidual job code.
The exposure intensity scores of none, low and 
high were arbitrarily assigned values of 0, 1 and 4 to 
reflect the log-normal (multiplicative) nature of occupa-
tional exposure concentrations. The cumulative expo-
sure scores per participant were calculated as follows: 
 
n∑
k=1
(
exposure intensity scorek x duration in yearsk x hours per weekk
)
40 , 
 
where k represents a job from the lifetime occupational history 
and n the total number of jobs reported for the entire working 
career. Estimated cumulative exposure was consequently cate-
gorised into low and high exposures derived by the median of 
exposed controls. Military service or periods spent as a home-
maker were excluded because of difficulties quantifying these 
activities. Because of considerable uncertainty about the expo-
sure estimates before the Second World War, in the main anal-
yses, we only included jobs starting after 1945 (>99% of all 
jobs).
statistical analysis
We used a multivariate logistic regression model to investigate 
the association between ALS risk and the occupational expo-
sures, adjusting for age at survey, gender, education, smoking, 
alcohol and cohort. All variables were calculated up to 3 years 
before survey date for both patients and controls to remove 
exposures that may have occurred after ALS onset.
We performed several additional analyses. First, when an 
occupational exposure showed a possible exposure–response 
association with ALS risk in the analysis of cumulative expo-
sure, we analysed this exposure while mutually adjusting for 
the other exposures. Second, we performed a jack-knife analysis 
subsequently excluding one of the cohorts to investigate whether 
the results were not particularly driven by one cohort. Third, 
we tested whether the association between ever/never expo-
sure to the seven exposures and ALS risk was different for men 
and women using an interaction term, and used the likelihood 
ratio test to compare the models with and without the inter-
action term. Fourth, since C9orf72 repeat expansions are the 
most common genetic abnormality in ALS, and patients with this 
mutation may represent a subgroup with different lifestyle and 
environmental factors, we excluded cases with a C9orf72 repeat 
expansion, determined by methods described previously.21 22 
Fifth, to explore the effect of educational level on the associ-
ation between the occupational exposures and risk of ALS, we 
matched one patient to one control based on age, gender, centre 
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Table 2 Cumulative occupational exposures and ALS risk
exposure
Cumulative 
exposure*
Patients (n=1252),
n (%)
Controls (n=2590),
n (%) Or† 95% CI P value P value for trend‡
Silica Never 1147 (85.7) 2410 (91.2) Ref 0.01
≤21.9 96 (7.2) 116 (4.4) 1.67 1.23 to 2.25 0.0008
>21.9 96 (7.2) 116 (4.4) 1.73 1.28 to 2.33 0.0003
Asbestos Never 1085 (81.0) 2228 (84.3) Ref. 0.68
≤15.0 127 (9.5) 209 (7.9) 1.22 0.95 to 1.56 0.12
>15.0 127 (9.5) 205 (7.8) 1.16 0.90 to 1.51 0.25
Organic dust Never 800 (59.7) 1755 (66.4) Ref 0.03
≤17.0 241 (18.0) 444 (16.8) 1.14 0.94 to 1.38 0.18
>17.0 298 (22.3) 443 (16.8) 1.33 1.11 to 1.59 0.002
Animal contact Never 1228 (91.7) 2457 (93.0) Ref. 0.72
≤29.3 59 (4.4) 93 (3.5) 1.16 0.81 to 1.64 0.40
>29.3 52 (3.9) 92 (3.5) 1.13 0.78 to 1.61 0.52
Endotoxin Never 976 (72.9) 2085 (78.9) Ref 0.13
≤12.0 175 (13.1) 282 (10.7) 1.22 0.98 to 1.51 0.08
>12.0 188 (14.0) 275 (10.4) 1.36 1.10 to 1.68 0.005
PAH Never 1129 (84.3) 2340 (88.6) Ref 0.24
≤8.6 91 (6.8) 151 (5.7) 1.12 0.84 to 1.49 0.45
>8.6 119 (8.9) 151 (5.7) 1.47 1.12 to 1.92 0.005
DME Never 1019 (76.1) 2131 (80.7) Ref 0.03
≤22.0 170 (12.7) 256 (9.7) 1.40 1.12 to 1.75 0.003
>22.0 150 (11.2) 255 (9.7) 1.21 0.96 to 1.53 0.11
*Low and high exposures based on control median: ≤median=low and >median=high; never exposed indicates background exposure, expressed in unit-years.
†Logistic regression, adjusted for age, gender, education, smoking, alcohol and cohort, background exposure as reference category.
‡P value for trend on a continuous scale.
ALS, amyotrophic lateral sclerosis; DME, diesel motor exhaust; PAH, polycyclic aromatic hydrocarbon.
Figure 1 pollutant models for silica with each of the other occupational 
exposures. The first row per exposure shows the OR with 95% cI of low 
versus background exposure, the second row shows this for high versus 
background exposure.
and educational level. In these ‘matched’ analyses, all expo-
sures were calculated up to onset of the disease of the patient 
for both the patient and the matching control, and we adjusted 
for smoking and alcohol. Sixth, we separately analysed the first 
and last jobs performed, and used an interaction term between 
the exposure intensity score and a newly created variable indi-
cating the first/last performed job, to test whether late exposure 
(as expressed by the last performed job) or early exposure (as 
expressed by the first performed job) exerted greater influence 
on ALS risk. If a person had more than one first/last job, the job 
with the highest occupational exposure concentrations was used. 
Lastly, we investigated whether the occupational exposures were 
associated with the phenotype of ALS. Using bulbar or spinal site 
of onset as dependent variable in a multivariate model with the 
same confounders as previously described, we determined if the 
association between ever/never exposure to the seven exposures 
and ALS was different for bulbar or spinal-onset patients. Addi-
tionally, we formally tested whether the occupational exposures 
modified the age at onset in patients using an interaction term 
between age at survey (for patients this is highly correlated with 
age at onset) and ever/never exposure.
resuLTs
study population and confounders
We included 1557 population-based cases and 2922 age, gender 
and geography-matched controls between 2011 and 2014 across 
three countries (table 1). Compared with cases, more controls 
completed higher levels of education. After exclusion of occupa-
tions starting before 1945, military occupations (28.7% patients 
and 29.7% controls performed at least one military job during 
their career), occupations with incomplete data (missing hours 
per week, start or stop year), or participants with missing data, 
1252 patients and 2590 controls with available occupational 
information remained.
single occupational exposure analyses
Most cases and controls (>50%) had only been exposed to back-
ground levels (‘never’; table 2). Compared with controls, cases 
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Figure 2 The main model for silica and subsequently excluding one of 
the cohorts. The first row per exposure shows the OR with 95% cI of low 
versus background exposure, the second row shows this for high versus 
background exposure.
Table 4 Overview of the additional analyses on cumulative occupational exposures and ALS risk
exposure
Analysis excluding C9orf72 patients Post hoc matched analysis
Cumulative exposure* Or 95% CI P value
Cumulative 
exposure* Or 95% CI P value
Silica Never Ref Never Ref
≤21.9 1.73 1.27 to 2.34 0.0004 ≤23.5 2.24 1.50 to 3.35 <0.0005
>21.9 1.69 1.24 to 2.28 0.0008 >23.5 2.13 1.42 to 3.20 <0.0005
Asbestos Never Ref Never Ref
≤15.0 1.24 0.96 to 1.60 0.10 ≤16.5 1.33 0.98 to 1.81 0.07
>15.0 1.21 0.92 to 1.56 0.16 >16.5 1.14 0.83 to 1.57 0.43
Organic dust Never Ref Never Ref
≤17.0 1.12 0.92 to 1.36 0.27 ≤20.0 1.31 1.03 to 1.66 0.03
>17.0 1.33 1.10 to 1.60 0.003 >20.0 1.56 1.23 to 1.99 <0.0005
Animal contact Never Ref Never Ref
≤29.3 1.22 0.85 to 1.73 0.28 ≤41.2 1.39 0.92 to 2.09 0.12
>29.3 1.23 0.85 to 1.76 0.28 >41.2 0.94 0.58 to 1.51 0.79
Endotoxin Never Ref Never Ref
≤12.0 1.23 0.98 to 1.54 0.07 ≤13.8 1.18 0.89 to 1.55 0.25
>12.0 1.33 1.07 to 1.65 0.01 >13.8 1.70 1.28 to 2.27 <0.0005
PAH Never Ref Never Ref
≤8.6 1.10 0.82 to 1.48 0.51 ≤10.0 1.12 0.80 to 1.57 0.51
>8.6 1.57 1.20 to 2.07 0.001 >10.0 1.36 0.96 to 1.91 0.08
DME Never Ref Never Ref
≤22.0 1.46 1.16 to 1.83 0.001 ≤26.2 1.35 1.03 to 1.75 0.03
>22.0 1.24 0.97 to 1.57 0.08 >26.2 1.04 0.77 to 1.39 0.82
*Low and high exposures in total study population based on control median: ≤median=low and >median=high; never exposed indicates background exposure.
ALS, amyotrophic lateral sclerosis; DME, diesel motor exhaust; PAH, polycyclic aromatic hydrocarbon.
were more frequently ever exposed, that is, to either low or high 
levels of all exposures. The risk of ALS was positively associ-
ated with all exposures, and statistically significant for high-level 
exposures to silica, organic dust, endotoxin and PAH. For silica 
and DME, statistically significant associations were observed for 
low levels of exposure. Treating the exposures as continuous 
predictors in the multivariate model resulted in significant linear 
associations for silica, organic dust and DME (table 2).
Combined exposure analyses
Since silica, organic dust and DME were significantly associated 
with ALS risk in both the categorical and continuous exposure 
analyses, we analysed these further by subsequently adding one 
of the other exposures to the model. Only the OR for silica 
remained significantly associated with ALS risk (figure 1). In 
contrast, the ORs for organic dust and DME decreased signifi-
cantly (>5% drop in OR) after adjustment for silica (data not 
shown).
Additional analyses
Except for low exposure in the Irish cohort, patients from all 
five cohorts were more frequently exposed to silica than controls 
(table 3). This difference in exposure was most obvious in the 
Lombardy region: 5%–10% of patients were exposed versus less 
than 1% of controls. Excluding the Lombardy cohort from the 
analysis, the association between silica and ALS risk remained 
(figure 2). Men and women had the same increased risk of ALS 
with the various types of exposures (all p values for interaction 
>0.11; data not shown). When we excluded 199 patients with a 
C9orf72 repeat expansion, the effect of exposure to silica on the 
risk of ALS remained the same: low versus background exposure 
OR 1.73 (95% CI 1.27 to 2.34) and high versus background 
exposure OR 1.69 (95% CI 1.24 to 2.28; table 4). The effect 
was in the same direction, although somewhat stronger, when 
matching one patient to one control based on age, gender, cohort 
and education: low versus background exposure OR 2.24 (95% 
CI 1.50 to 3.35) and high versus background exposure OR 2.13 
(95% CI 1.42 to 3.20; table 4). We found positive associations 
between all exposures and ALS risk for both the first and the last 
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held jobs, with significant associations for silica and the highest 
category of organic dusts and endotoxin. This was confirmed by 
all seven insignificant interaction terms (all p values for interac-
tion >0.41; data not shown).
Phenotype
We did not find any suggestion that the occupational exposures 
were associated with a different site of onset, that is, bulbar and 
spinal patients were equally exposed (data not shown). Regarding 
the age at onset, we found a younger age at survey (for patients 
this was highly correlated with age at onset) for patients exposed 
(mean of 63.5 years) to asbestos when compared with patients 
who were non-exposed (mean of 64.9 years). This was not found 
for any of the other six occupational exposures.
dIsCussION
In this large, multicentre, population-based, case–control 
study, we found an association between occupational exposure 
to particulates and combustion products and the risk of ALS. 
However, this association appeared only noteworthy for expo-
sure to silica, independent of important confounders, such as 
age, gender, education, smoking and alcohol, gathered using a 
validated and methodologically harmonised questionnaire, and 
after adjustment for the other occupational exposures. The 
exposure-response trend seen for silica, that is, increasing ORs 
with higher level of exposure, together with the significant linear 
association, strengthens the robustness of our results.
To the best of our knowledge, this is the first study describing 
the association between silica and risk of ALS. There are studies, 
however, that describe associations with occupations in which 
silica could play a role: a recent nested case–control study 
with prospectively collected data on 1826 cases and 1 826 000 
controls showed higher odds of ALS for male construction 
workers, adjusted for socioeconomic status, residential location 
and marital status.23 A finding consistent with results from two 
other case-control studies.11 24 In a prospective study using ALS 
mortality data, on the other hand, the authors did not find an 
association with occupations in which silica exposure could play 
a role, possibly due to limited power.13
Rather than studying occupational groups without informa-
tion on potential underlying risk factors, we were able to study 
a large group of population-based patients and controls with 
respect to the specific elements to which they were exposed to. 
Moreover, we had information on several occupational expo-
sures, which made it possible to correct for another exposure 
in a bipollutant model. In this study, participants were essen-
tially blinded for the hypothesis being tested; the questionnaire 
contained questions on many other exogenous factors. However, 
recall bias cannot be completely ruled out as it is a commonly 
held belief in the general public that occupational exposures can 
lead to neurodegenerative disease and therefore patients may be 
more likely to have thought through and recalled details that 
may not have seemed important to controls.
The observed effect of silica would seem to be driven by the 
Lombardy region (table 3), but this region accounts for only 10% 
of the total study population and when subsequently excluding 
one cohort as a sensitivity analysis, the ORs remain stable 
(figure 2). This regional variation cannot be explained by differ-
ential recall or systemic measurement bias (face-to-face inter-
views in Ireland and Italy and self-administered questionnaires 
in the Netherlands), as occupational exposures were objectively 
assessed by the application of JEMs. The difference in educa-
tional level between cases and controls was most prominent in 
the Lombardy region (table 1). The regional variation, however, 
was not explained by selection bias on educational level since 
the effect sizes become even stronger after one-to-one matching 
of patients and controls for education (table 4). The median 
levels of exposure differed between cohorts (table 3), while 
in the main analyses we pooled all controls in order to create 
low and high exposure groups. Therefore, in order to rule out 
possible aggregation bias, we additionally performed a meta-re-
gression analysis confirming the association with silica exposure 
(table 3). We included 86% of patients and 90% of controls after 
exclusion due to incomplete data, occupations starting before 
1945 or military occupations. It would have been interesting to 
include military activities, as some military personnel are prob-
ably highly exposed to some of the studied constituents during 
training and operations. We had to exclude these occupations 
because the exposures could easily be misclassified due to the 
diversity of job activities that can be performed within the mili-
tary service. We excluded the same percentage of activities in 
patients and controls (~29%). Moreover, a well-recognised 
limitation of using JEMs is that every person performing the 
same job is assigned an equal exposure (intensity), but not every 
person performs the same tasks in the same way.25 However, 
this probably does not lead to differential misclassification. With 
regard to silica exposure, compared with case-by-case expert 
assessment, the DOM-JEM has shown good performance in a 
multicentre study on lung cancer.18
Silica exists in numerous forms in nature; of which inhaled 
crystalline silica is studied most frequently regarding its toxic 
effects. The toxicity most likely depends on particle size, with 
the respirable fraction that reaches the alveoli of the lungs being 
the fraction of interest with respect to health effects.26 As an 
element of particulate matter, silica could reach the brain by 
translocation through the systemic circulation following depo-
sition in the pulmonary region after inhalation. Particulate 
matter has been hypothesised to be neurotoxic, mainly through 
potentially increased oxidative stress and increased activation of 
brain microglia, the primary regulators of neuroinflammation.27 
One should note, however, that this is based on indirect infer-
ences since silica has never been specifically studied as an ALS 
risk factor. If future studies confirm our findings, it would be 
interesting to perform gene/silica interaction studies. Assuming 
oxidative stress and neuroinflammation are the pathogenic 
mechanisms, interaction with mutations in the gene encoding 
Cu/Zn superoxide dismutase (SOD1) could be of added value. 
Especially since this mutation is common in Italy, but rare in 
Ireland and the Netherlands.28–30
This is the first study to explore the association between 
particulates and combustion products and ALS risk using JEMs. 
In this large, multicentre, population-based, case-control study 
using full job histories, we found a positive association between 
occupational silica exposure and the risk of ALS.
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